FINCH THERAPEUTICS GROUP, INC. Earnings Per Share, Basic and Diluted
FINCH THERAPEUTICS GROUP, INC. reported Earnings Per Share, Basic and Diluted of -$0.48 per share for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-08-11
- FINCH THERAPEUTICS GROUP, INC. earnings per share, basic and diluted for the quarter ending 2022-06-30 was -$0.48.
- FINCH THERAPEUTICS GROUP, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.52.
- FINCH THERAPEUTICS GROUP, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.40.
- FINCH THERAPEUTICS GROUP, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.21.
- FINCH THERAPEUTICS GROUP, INC. earnings per share, basic and diluted for fiscal 2021 was -$1.48.
- FINCH THERAPEUTICS GROUP, INC. earnings per share, basic and diluted for fiscal 2020 was -$4.83.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$0.48 10-Q · filed 2022-08-11 | -$0.99 10-Q · filed 2022-08-11 | -$1.39 derived: net income ÷ weighted average shares · filed 2023-08-11 | -$1.60 derived: net income ÷ weighted average shares · filed 2023-08-11 |
| 2022-03-31 | -$0.52 10-Q · filed 2022-05-16 | -$0.92 derived: net income ÷ weighted average shares · filed 2023-05-10 | -$1.13 derived: net income ÷ weighted average shares · filed 2023-05-10 | -$1.45 derived: net income ÷ weighted average shares · filed 2023-05-10 |
| 2021-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$0.61 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$0.93 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.48 10-K · filed 2022-03-31 |
| 2021-09-30 | -$0.21 10-Q · filed 2021-11-10 | -$0.53 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.07 10-Q · filed 2021-11-10 | -$1.78 derived: net income ÷ weighted average shares · filed 2022-11-10 |
| 2021-06-30 | -$0.32 10-Q · filed 2022-08-11 | -$0.95 10-Q · filed 2022-08-11 | -$1.82 derived: net income ÷ weighted average shares · filed 2022-08-11 | -$2.68 derived: net income ÷ weighted average shares · filed 2022-08-11 |
| 2021-03-31 | -$1.00 10-Q · filed 2022-05-16 | -$2.42 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$3.63 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$4.69 derived: net income ÷ weighted average shares · filed 2022-05-16 |
| 2020-12-31 | -$1.56 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$2.79 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$3.82 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$4.83 10-K · filed 2022-03-31 |
| 2020-09-30 | -$1.22 10-Q · filed 2021-11-10 | -$2.25 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$3.25 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$1.02 10-Q · filed 2021-08-10 | -$2.03 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | -$1.00 10-Q · filed 2021-05-13 |